Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-10

Clinical Trial Update: The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia [Phase 1, Phase 2]

View source ↗

Summary

The study evaluated Jobelyn (sorghum bicolor extract) for treating sickle cell anemia in Phase 1 and Phase 2. The trial status is completed with Lagos State Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jobelyn

Snippet

Sponsor: Lagos State University | Conditions: Sickle Cell Anemia | Phase 1, Phase 2 | Status: COMPLETED